270 related articles for article (PubMed ID: 37403147)
1. Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review.
Aderoba AK; Steyn PS; Kiarie JN
Syst Rev; 2023 Jul; 12(1):114. PubMed ID: 37403147
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the Introduction and Scale Up of Self-Administered Injectable Contraception (DMPA-SC) in Health Systems (the EASIER Project): Protocol for Embedded Implementation Research.
Baynes C; Steyn PS; Sherr K; Kiarie J
JMIR Res Protoc; 2023 Aug; 12():e44222. PubMed ID: 37610819
[TBL] [Abstract][Full Text] [Related]
3. Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
Kohn JE; Berlan ED; Tang JH; Beasley A
Contraception; 2022 Aug; 112():11-13. PubMed ID: 35378085
[TBL] [Abstract][Full Text] [Related]
4. Expanding Access to Injectable Contraception: Results From Pilot Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in 4 African Countries.
Stout A; Wood S; Barigye G; Kaboré A; Siddo D; Ndione I
Glob Health Sci Pract; 2018 Mar; 6(1):55-72. PubMed ID: 29602866
[TBL] [Abstract][Full Text] [Related]
5. Implementation strategies, facilitators, and barriers to scaling up and sustaining task-sharing in family planning: a protocol for a mixed-methods systematic review.
Aderoba AK; Kabra R; Kiarie JN
Syst Rev; 2023 Oct; 12(1):190. PubMed ID: 37805571
[TBL] [Abstract][Full Text] [Related]
6. Scale-up of the DMPA-SC in Nigeria: Why policy matters.
Akinyemi O; Danfakha N; Adefalu A; Easley E; Afolabi K; Latunji O
BMC Womens Health; 2022 Dec; 22(1):535. PubMed ID: 36544189
[TBL] [Abstract][Full Text] [Related]
7. Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial.
Burke HM; Chen M; Buluzi M; Fuchs R; Wevill S; Venkatasubramanian L; Dal Santo L; Ngwira B
Lancet Glob Health; 2018 May; 6(5):e568-e578. PubMed ID: 29526707
[TBL] [Abstract][Full Text] [Related]
8. Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi.
Burke HM; Packer C; Buluzi M; Healy E; Ngwira B
Contraception; 2018 Nov; 98(5):405-410. PubMed ID: 29706227
[TBL] [Abstract][Full Text] [Related]
9. Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States.
Upadhyay UD; Zlidar VM; Foster DG
Contraception; 2016 Oct; 94(4):303-13. PubMed ID: 27326938
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate.
Beasley A; White KO; Cremers S; Westhoff C
Contraception; 2014 May; 89(5):352-6. PubMed ID: 24656555
[TBL] [Abstract][Full Text] [Related]
11. "Men can take part": examining men's role in supporting self-injectable contraception in southern Malawi, a qualitative exploration.
Ruderman LW; Packer C; Zingani A; Moses P; Burke HM
Reprod Health; 2022 Aug; 19(1):174. PubMed ID: 35945601
[TBL] [Abstract][Full Text] [Related]
12. An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
Katz M; Newmark RL; Aronstam A; O'Grady N; Strome S; Rafie S; Karlin J
Contraception; 2020 Dec; 102(6):392-395. PubMed ID: 32931811
[TBL] [Abstract][Full Text] [Related]
13. Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate.
Curtis KM; Nguyen A; Reeves JA; Clark EA; Folger SG; Whiteman MK
MMWR Morb Mortal Wkly Rep; 2021 May; 70(20):739-743. PubMed ID: 34014910
[TBL] [Abstract][Full Text] [Related]
14. The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review.
Dragoman MV; Gaffield ME
Contraception; 2016 Sep; 94(3):202-15. PubMed ID: 26874275
[TBL] [Abstract][Full Text] [Related]
15. Continuation of self-injected versus provider-administered contraception in Senegal: a nonrandomized, prospective cohort study.
Cover J; Ba M; Drake JK; NDiaye MD
Contraception; 2019 Feb; 99(2):137-141. PubMed ID: 30439358
[TBL] [Abstract][Full Text] [Related]
16. Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
Smith TJ; Urdanigo TK; Shroff N; Rubin SE
Contraception; 2023 Jul; 123():110008. PubMed ID: 36931548
[TBL] [Abstract][Full Text] [Related]
17. Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal.
Di Giorgio L; Mvundura M; Tumusiime J; Namagembe A; Ba A; Belemsaga-Yugbare D; Morozoff C; Brouwer E; Ndour M; Drake JK
Contraception; 2018 Nov; 98(5):389-395. PubMed ID: 29859148
[TBL] [Abstract][Full Text] [Related]
18. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
19. Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda.
MacLachlan E; Atuyambe LM; Millogo T; Guiella G; Yaro S; Kasasa S; Bukenya J; Nyabigambo A; Mubiru F; Tumusiime J; Onadja Y; Zan LM; Goeum/Sanon C; Kouanda S; Namagembe A
Contraception; 2018 Nov; 98(5):423-429. PubMed ID: 30125558
[TBL] [Abstract][Full Text] [Related]
20. Injectable contraception: emerging evidence on subcutaneous self-administration.
Lerma K; Goldthwaite LM
Curr Opin Obstet Gynecol; 2019 Dec; 31(6):464-470. PubMed ID: 31567445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
